November #118 : Med Blues - by Rebecca Minnich

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

Senior Class

A Place at the Table

Food for the Soul

Med Blues

Doctor's Diary - November 2005

Talking Turkey

Licking Lipo Where it Lives

Tea Cells

Ask the Sexpert - November 2005

Bedroom Gambling

Word Therapy

Employee of the Month - November 2005

No More Stickups

Postscripts from the Edge

Buzz - November 2005

Positive I.D.

Courting Disaster?

Rent's Due

Mentors - November 2005

Pushing the $$$ Envelope

I Demand a Recount

We are Family

Founder's Letter - November 2005

Mailbox - November 2005

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

November 2005

Med Blues

by Rebecca Minnich

When drugs cost too much

Price hikes on HIV drugs, averaging 28% since 2003 according to an AIDS Treatment Activist Coalition report, are straining health systems—and HIVers are feeling the pinch. Treatment activist Nelson Vergel, 46, who runs Houston’s Program for Wellness Restoration, has seen his med costs creep up—and now coughs out $1,000 monthly. “It’s like another rent,” he says, “and I’m lucky. I work with people on AIDS Drug Assistance Program wait lists every day.” New drugs Reyataz and Aptivus debuted as the most expensive in their class, implying that without pricing regulations, costs will keep climbing.

“Doctors tell me they don’t even bother prescribing Fuzeon (the most expensive of all HIV meds) because some state’s ADAP can’t cover it,” says Vergel. ADAP wait lists would shorten if drugs were more affordable, he adds. Many states are beginning to restrict the number of drugs that Medicaid will cover for each patient, while private insurers amp up copays and premiums. Most European nations, meanwhile, have laws freezing drug prices. While the U.S. cost for HIV med Norvir has shot up 400% since 2003, the European tab has remained steady.

The U.S. has no price-freezing legislation—yet. A proposed California law would require companies to offer cheap meds to a new state drug program. Members of the Community Catalyst Prescription Access Litigation Project, a health-care advocacy group, filed a suit in 2001 against 19 drug companies for artificially inflating prices, which if successful could force down costs, saving millions. “Regulations won’t change until people start demanding it,” says Vergel. “There is no reason for drugs to cost this much.” When meds cost as much as a house, it’s time for remodeling.                              

Quick tips to get meds
Ask your doc:
  • To connect you to an HIV case manager with drug-benefits expertise.
  • About patient-assistance programs. Also check out programs at
  • For info on clinical trials for new approved drugs.

Plus, check out ATAC,, and lobby for treatment reform.

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.